Clinical Trials Browser

Phase 2 × INDUSTRY × CTLA-4 Antigen × Clear all

NCT00050102 2011-01-28

Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma

Phase 2 Completed

Melanoma